The Valley Desk

ArticleJournal of medicinal chemistryPublished

Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Journal of medicinal chemistry
Published
Subject terms
Humans; Sulfur Compounds; Pyrimidines; Phosphoric Diester Hydrolases; Phosphodiesterase Inhibitors; Crystallography, X-Ray; Schizophrenia; Structure-Activity Relationship
PubMed ID
36624931
PubMed Central ID
PMC9884086
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal